<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">FNS</journal-id><journal-title-group><journal-title>Food and Nutrition Sciences</journal-title></journal-title-group><issn pub-type="epub">2157-944X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/fns.2018.91002</article-id><article-id pub-id-type="publisher-id">FNS-81876</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Myricetin and Hesperidin Inhibit Cerebral Thrombogenesis and Atherogenesis in &lt;i&gt;Apoe&lt;sup&gt;-/-&lt;/sup&gt;&lt;/i&gt; and &lt;i&gt;Ldlr&lt;sup&gt;-/-&lt;/sup&gt;&lt;/i&gt; Mice
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yasuto</surname><given-names>Sasaki</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kanae</surname><given-names>Hyodo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ayana</surname><given-names>Hoshino</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Eri</surname><given-names>Kisa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Koichi</surname><given-names>Matsuda</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yoko</surname><given-names>Horikawa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>John</surname><given-names>C. Giddings</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Haematology, School of Medicine, Cardiff University, Cardiff, UK</addr-line></aff><aff id="aff1"><addr-line>Laboratory of Physiology, Faculty of Nutrition, Kobe Gakuin University, Kobe, Japan</addr-line></aff><aff id="aff2"><addr-line>Laboratory of Biochemistry, Faculty of Nutrition, Kobe Gakuin University, Kobe, Japan</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>sasakiya@nutr.kobegakuin.ac.jp(YS)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>01</month><year>2018</year></pub-date><volume>09</volume><issue>01</issue><fpage>20</fpage><lpage>31</lpage><history><date date-type="received"><day>26,</day>	<month>December</month>	<year>2017</year></date><date date-type="rev-recd"><day>19,</day>	<month>January</month>	<year>2018</year>	</date><date date-type="accepted"><day>22,</day>	<month>January</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    Flavonoids have been reported to possess strong antioxidant activities that moderate endothelial dysfunction and demonstrate protective effects on cardiovascular disease. Our previous studies confirmed that flavonoids, including hesperidin, naringin and nobiletin, inhibited thrombogenesis and hypertension in stroke prone spontaneously hypertensive rats (SHRSP) by protecting the endothelium from the adverse effects of free radical formation. We have now further investigated the protective effects of myricetin and hesperidin on cerebral thrombosis and atherogenesis in apolipoprotein E (apoE) and lowdensity lipoprotein receptor (LDLR) deficient (
   
   Apoe<sup>-/-</sup> and 
   
   Ldlr<sup>-/-</sup> double knockout) mice. Three groups of mice were fed high fat diet alone and high fat diet mixed with myricetin (100 mg/kg/day and 200 mg/kg/day) or glucosyl hesperidin (G-hesperidin; 250 mg/kg/day and 500 mg/kg/day) for 8 weeks. There were no differences in body weight related to administration of the flavonoids. Thrombotic tendency was assessed using a He-Ne laser technique in the murine cerebral pial vessels. In addition, atherogenesis was quantified histologically after dissection of the aorta from each mouse and staining with Oil Red O solution. The percentages of stained area to whole area of dissected aorta were calculated as indices of anti-atherogenic activity. Both myricetin and G-hesperidin significantly inhibited thrombogenesis in vivo and significantly inhibited atherogenesis compared to control mice (
   
   p &lt; 0.001). These findings demonstrated that daily intake of myricetin and hesperidin suppressed the development of atherogenesis and thrombogenesis, possibly associated with the potent antioxidant effects of the flavonoids. 
  
 
</p></abstract><kwd-group><kwd>Myricetin</kwd><kwd> Hesperidin</kwd><kwd> Atherosclerosis</kwd><kwd> &lt;i&gt;Apoe&lt;sup&gt;-/-&lt;/sup&gt;&lt;/i&gt; and &lt;i&gt;Ldlr&lt;sup&gt;-/-&lt;/sup&gt;&lt;/i&gt; Mice</kwd><kwd> Thrombosis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Flavonoids are polyphenolic compounds present in substantial amounts in plants. They exert multiple biological effects, including antioxidant activity [<xref ref-type="bibr" rid="scirp.81876-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref2">2</xref>] , anti-inflammatory [<xref ref-type="bibr" rid="scirp.81876-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref4">4</xref>] , anti-cancer [<xref ref-type="bibr" rid="scirp.81876-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref6">6</xref>] and neuroprotective properties [<xref ref-type="bibr" rid="scirp.81876-ref7">7</xref>] . Lipid oxidation has been recognized as the major source of deteriorative changes in the nutritional properties of fats and oils, and the anti-oxidative effects of flavonoids improve the stability of lipid containing foods. In addition, lipid oxidation has been shown to be associated with disturbances in the structure and functional loss of cell membranes, and oxidative modification appears to be an important initial event for the pathogenesis of atherosclerosis [<xref ref-type="bibr" rid="scirp.81876-ref8">8</xref>] . The potential beneficial effects of flavonoids on inhibiting the oxidation of low-density lipoproteins (LDL) and promoting anti-atherogenesis is believed to be beneficial for human health [<xref ref-type="bibr" rid="scirp.81876-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref10">10</xref>] .</p><p>Myricetin (<xref ref-type="fig" rid="fig1">Figure 1</xref>) is a well-defined flavonol with hydroxyl substitutions at 3, 5, 7, 3', 4' and 5' molecular sites, and occurs naturally in tea, fruits, berries, vegetables and medicinal herbs [<xref ref-type="bibr" rid="scirp.81876-ref11">11</xref>] . The role of myricetin as an antioxidant appears to be especially distinguished as an anti-carcinogen and in the treatment of type 2 diabetes mellitus [<xref ref-type="bibr" rid="scirp.81876-ref12">12</xref>] . In addition, myricetin has been found to be effective in scavenging free radicals [<xref ref-type="bibr" rid="scirp.81876-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref13">13</xref>] and inhibiting the formation of malondialdehyde (MDA) from arachidonic acid when lipids undergo peroxidation [<xref ref-type="bibr" rid="scirp.81876-ref14">14</xref>] .</p><p>Hesperidin, a citrus flavonoid also exerts numerous pharmacological activities including strong antioxidant effects [<xref ref-type="bibr" rid="scirp.81876-ref15">15</xref>] , and our previous studies have shown that compounds of this nature, such as glucosyl hesperidin (G-hesperidin; <xref ref-type="fig" rid="fig1">Figure 1</xref>), naringin and nobiletin, improved endothelial function, and suppressed hypertension and thrombotic tendency possibly through antioxidant effects in stroke prone spontaneously hypertensive rats (SHRSP) [<xref ref-type="bibr" rid="scirp.81876-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref17">17</xref>] . The evidence suggested that free radicals generated in the vicinity of the endothelium reduced endothelial function, caused vasoconstriction and led to increases in blood pressure and an enhanced thrombotic tendency.</p><p>Demonty, et al. [<xref ref-type="bibr" rid="scirp.81876-ref18">18</xref>] reported, however, that citrus flavonoids did not affect serum cholesterol in moderately hypercholesterolemic men and women. Nevertheless, increases in oxidized LDL-cholesterol and triglyceride are known to be risk factors for atherosclerosis [<xref ref-type="bibr" rid="scirp.81876-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref20">20</xref>] . Apolipoprotein E (ApoE) and LDL receptor (LDLR) deficient (Apoe<sup>−/−</sup> and Ldlr<sup>−/−</sup> double knockout) mice have been used in studies of atherosclerosis [<xref ref-type="bibr" rid="scirp.81876-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref22">22</xref>] . These double mutant mice demonstrate cholesterol and lipoprotein profiles similar to Apoe<sup>−/−</sup> single mutant mice but reportedly develop atherosclerotic plaques even more rapidly than the</p><p>Apoe<sup>−/−</sup> single knockout animals. Similarly, Ldlr deficient mice that were engineered to express only the ApoB-100 isoform, appeared to develop larger atherosclerotic plaques than age matched the Apoe<sup>−/−</sup> knockout mice, despite having similar total serum cholesterol levels [<xref ref-type="bibr" rid="scirp.81876-ref23">23</xref>] . The data suggested that the double- mutant mouse model offered benefits in studies of the effects of myricetin and G-hesperidin on atherosclerosis in a relatively short time-scale.</p><p>The present study was designed, therefore, to further clarify the anti-atherogenic and antithrombotic effects of myricetin and G-hesperidin utilizing these genetically sensitive Apoe<sup>−/−</sup> and Ldlr<sup>−/−</sup> double knockout mice.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Animals</title><p>Apolipoprotein E (ApoE) and low-density lipoproteins receptor (LDLR) deficient mice (Apoe<sup>−/−</sup> and Ldlr<sup>−/−</sup> double knockout mice, 129xC57BL/6J background) were obtained from Jackson Laboratory (Bar Harbor, ME, USA) and bred in Kobe Gakuin University. All experiments were conducted in accordance with the ethical principles of animal care of Kobe Gakuin University and the guiding principles for the care and use of animals in the field of physiological sciences published by the Physiological Society of Japan [<xref ref-type="bibr" rid="scirp.81876-ref24">24</xref>] . Euthanasia was performed by CO<sub>2</sub> inhalation or cervical dislocation after experiments. Myricetin, purity more than 97% was purchased from Tokyo Chemical Industry Co., Ltd., Tokyo, Japan and glucosyl hesperidin (G-hesperidin; purity of 78.8%) was kindly provided by Toyo Sugar Refining Co., Ltd, Tokyo, Japan. Control animals (N = 8) were fed high fat diet (F2HFD1), obtained from Oriental Yeast Co., LTD., Tokyo, Japan, to induce atherosclerosis. Myricetin or G-hesperidin were mixed with the high fat diet at concentrations of 0.06% and 0.12% and 0.3% and 0.6%, respectively. The animals (N = 8 in each group) were given myricetin diet or G-hesperidin diet and water ad libitum. Each animal was kept in an individual cage and water and food were changed at 9:00 am every day. Consumption was assessed by weighing the diet and water on each occasion. The daily average doses of myricetin and G-hesperidin, calculated from the food intake in each group were adjusted to approximately 100 and 200 mg/kg animal body weight/day [<xref ref-type="bibr" rid="scirp.81876-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref26">26</xref>] and 250 mg/kg and 500 mg/kg animal body weight/day [<xref ref-type="bibr" rid="scirp.81876-ref16">16</xref>] , respectively (<xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> The experimental protocols</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Control (N = 8)</th><th align="center" valign="middle" >Myricetin (N = 8)</th><th align="center" valign="middle" >G-hesperidin (N = 8)</th></tr></thead><tr><td align="center" valign="middle" >Diet</td><td align="center" valign="middle" >High Fat Diet (F2HFD1)</td><td align="center" valign="middle" >F2HFD1 + myricetin 100 mg/kg/day</td><td align="center" valign="middle" >F2HFD1 + G-hesperidin 250 mg/kg/day</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >F2HFD1 + myricetin 200 mg/kg/day</td><td align="center" valign="middle" >F2HFD1 + G-hesperidin 500 mg/kg/day</td></tr><tr><td align="center" valign="middle" >Period</td><td align="center" valign="middle" >for 8 weeks</td><td align="center" valign="middle" >for 8 weeks</td><td align="center" valign="middle" >for 8 weeks</td></tr><tr><td align="center" valign="middle" >Measurement</td><td align="center" valign="middle" >thrombotic tendency atherosclerosis</td><td align="center" valign="middle" >thrombotic tendency atherosclerosis</td><td align="center" valign="middle" >thrombotic tendency atherosclerosis</td></tr></tbody></table></table-wrap></sec><sec id="s2_2"><title>2.2. Measurement of Thrombotic Tendency</title><p>Closed cranial windows were created as described by Morii et al. [<xref ref-type="bibr" rid="scirp.81876-ref27">27</xref>] and thrombotic tendency was measured as reported previously [<xref ref-type="bibr" rid="scirp.81876-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref28">28</xref>] .</p><p>In brief, animals were ventilated artificially after anesthetizing and Evans blue was administered through a femoral vein. Closed cranial windows were formed with 2 mm diameter in the right parietal bone and artificial cerebrospinal fluid was infused continuously within this window. The animals were placed in a stereotaxic frame on the stage of an optical microscope and the cerebral vessels on the surface of the brain were monitored and recorded on videotape with a CCD camera (Pulnix, Takenaka System, Kyoto). A He-Ne laser beam (15 μm in diameter) was focused on the center of selected blood vessels through the optical path of the microscope and thrombi were formed in venules (25 - 40 μm) by repeated irradiation for 10 s at 20 s intervals at a power of 13 mW. The number of laser pulses required to generate an occlusive thrombus was used as an index of thrombotic tendency.</p></sec><sec id="s2_3"><title>2.3. Measurement of Atherosclerosis</title><p>Arteriosclerosis was assessed by estimating the development of atherosclerotic lesions as a percent of the entire surface area of the aorta [<xref ref-type="bibr" rid="scirp.81876-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref30">30</xref>] . Briefly, hearts were exposed by abdominal incision and 50 mL of phosphate buffered saline (pH 7.4) infused through butterfly needle, followed by 10% neutral buffered formalin solution by reflex through a femoral artery. The aortic arch was carefully dissected from connective tissue and minor branching blood vessels. The extracted vessels were kept in 10% neutral buffered formalin solution until processed. The vessels were then incised along the longitudinal plane, inverted on a black rubber sheet and held in place using stainless steel pins. The tissue was washed with distilled water for 30 s, treated with 60% isopropyl alcohol for 1 min, and stained with Oil Red O stain solution at 37˚C for 15 min. Finally, the vessel was washed with 60% isopropyl alcohol and distilled water.</p><p>The Oil Red O stained specimens were photographed using a digital camera (Olympus Tokyo Japan). Images were transferred to a PC and analyzed using NIH Image. The entire area of the dissected blood vessels and the area of atherosclerotic lesions identified by Oil Red O staining were calculated. The percentages of Oil Red O staining area to entire area were used as an index of atherosclerotic development.</p></sec><sec id="s2_4"><title>2.4. Statistical Analyses</title><p>The results illustrate the number of animals (N) and the mean and standard error (SEM) of each experiment. Statistical evaluation was performed by one-way analysis of variance (ANOVA), by the post hoc test of Dunnett and Mann-Whitney test using commercially available statistical packages (Prism 5.0; GraphPad Software, Inc., San Diego, CA, USA). A value of p &lt; 0.05 was considered to be statistically significant.</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><sec id="s3_1"><title>3.1. Changes in Body Weight by Myricetin and G-Hesperidin in Apoe<sup>−/−</sup> and Ldlr<sup>−/−</sup> Double Knockout Mice</title><p>The doses of myricetin (100 and 200 mg/kg/day) and G-hesperidin (250 and 500 mg/kg/day) were adjusted every day for 8 weeks, respectively by weighing the consumption of high fat diet (F2HFD1) mixed with myricetin or G-hesperidin. Changes in body weight over time after administration of myricetin and G-hesperidin from 8 weeks of age up to 16 weeks of age are shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>. The body weights increased with age, and there were no statistically significant differences among these groups.</p></sec><sec id="s3_2"><title>3.2. Suppression of Thrombogenesis by Myricetin and G-Hesperidin in the Pial Vessels of Apoe<sup>−/−</sup> and Ldlr<sup>−/−</sup> Double Knockout Mice</title><p>Thrombogenesis in cerebral vessels for each group of animals, as assessed by the He-Ne laser technique, is summarized in <xref ref-type="fig" rid="fig3">Figure 3</xref>. The number of laser pulses</p><p>required to generate occlusive thrombi in pial vessels in control and myricetin-fed mice at 100 and 200 mg/kg/day were 3.9 &#177; 0.2 (N = 5), 5.8 &#177; 0.5 (N = 4), 6.4 &#177; 0.4 (N = 5), respectively and G-hesperidin-fed animals at 250 and 500 mg/kg/day were 6.0 &#177; 0.6 (N = 4) and 7.5 &#177; 0.2 (N = 8), respectively. Thrombus generation was significantly delayed at both concentrations of myricetin and G-hesperidin as shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>. (p &lt; 0.01 and p &lt; 0.001). These results were consistent with our former studies demonstrating that flavonoids, including hesperidin, naringin and nobiletin, inhibited thrombus generation, possibly by scavenging free radicals and resulting in increased nitric oxide (NO) which inhibits platelet aggregation [<xref ref-type="bibr" rid="scirp.81876-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref17">17</xref>] . Our new data provided further evidence that mechanisms underlying the effects of the flavonoids were related to strong antioxidative properties.</p><p>Mechanisms of He-Ne laser induced thrombus generation in small blood vessels may depend on free radical and/or active oxygen produced in response to laser irradiation [<xref ref-type="bibr" rid="scirp.81876-ref31">31</xref>] , and such reactive oxygen species (ROS) may be involved in vascular dysfunction. ROS reduce levels of bioactive NO by conversion into toxic peroxynitrite (ONOO<sup>−</sup>) leading to a deterioration in protective endothelial function [<xref ref-type="bibr" rid="scirp.81876-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref33">33</xref>] . Povlishock demonstrated that the endothelial dysfunction caused by He-Ne laser irradiation induced platelet aggregation without cell-surface denudation [<xref ref-type="bibr" rid="scirp.81876-ref34">34</xref>] . Furthermore, Wachowicz concluded that ROS are produced during platelet aggregation and play an important role in platelet function [<xref ref-type="bibr" rid="scirp.81876-ref35">35</xref>] . Other studies have shown, however, that flavonoids blocked platelet aggregation by inhibiting thromboxane receptors [<xref ref-type="bibr" rid="scirp.81876-ref36">36</xref>] or thromboxane A<sub>2</sub> [<xref ref-type="bibr" rid="scirp.81876-ref37">37</xref>] .</p><p>In alternative studies, Rong et al. reported that hesperidin pretreatment protected neonatal rats from brain injury by reducing free radicals [<xref ref-type="bibr" rid="scirp.81876-ref38">38</xref>] , and Mastantuono et al. also reported that hesperidin, diosmin, and apigenin had dose-related protective effects on microvascular damage induced by hypoperfusion and reperfusion in the rat pial circulation, possibly related to a decrease in ROS production [<xref ref-type="bibr" rid="scirp.81876-ref39">39</xref>] .</p><p>Our previous studies indicated that the antioxidant activity of G-hesperidin inhibited He-Ne laser induced thrombosis by scavenging ROS [<xref ref-type="bibr" rid="scirp.81876-ref16">16</xref>] , and overall the present studies are consistent with the likelihood that the adverse effects of ROS produced by laser irradiation and platelet aggregation were moderated by the flavonoids</p></sec><sec id="s3_3"><title>3.3. Effects of Myricetin and G-Hesperidin on Atherogenesis in Apoe<sup>−/−</sup> and Ldlr<sup>−/−</sup> Double Knockout Mice</title><p>The entire area of the dissected blood vessels and the area of atherosclerotic lesions identified by Oil Red O staining in control, myricetin at 200 mg/kg/day and G-hesperidin at 500 mg/kg/day are shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>. The lipid-stained areas in control were dominant and clear, as compared to myricetin and G-hesperidin treated aorta. The severity of atherogenesis, as expressed as percentages of lipid-stained areas to entire area of the aorta is shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>. The percentages in control, myricetin and G-hesperidin treated mice were 33.4 &#177; 3.1% (N = 8), 14.2 &#177; 2.3% (N = 8; p &lt; 0.001 vs. control) and 22.0 &#177; 1.4% (N = 8; p &lt; 0.001 vs. control), respectively. The data clearly demonstrated that the control</p><p>Apoe<sup>−/−</sup> and Ldlr<sup>−/−</sup> double knockout mice fed high fat diet for eight weeks accumulated lipid over approximately about one third of the entire aorta, and that the flavonoids significantly prevented this deposit of lipid.</p><p>Therapeutic flavonoids including quercetin, kaempferol, myricetin, apigenin, and luteolin are well known to reduce the incidence of coronary disease in elderly humans [<xref ref-type="bibr" rid="scirp.81876-ref11">11</xref>] . Atherosclerosis is widely considered to be a chronic inflammatory disease, and excess ROS, generated by oxidative stress, has emerged as a critical common mechanism involved in vascular injury in both the development and progression of atherosclerosis [<xref ref-type="bibr" rid="scirp.81876-ref20">20</xref>] . It is generally believed that the potent antioxidant activity of polyphenols and their inhibitory effects on LDL oxidation support antiatherogenic properties [<xref ref-type="bibr" rid="scirp.81876-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.81876-ref10">10</xref>] . In addition, Bertin et al. reported that myricetin appeared to be the most active of selected plant-derived polyhydroxyl compounds, with prominent capacities against oxidized LDL and ROS production [<xref ref-type="bibr" rid="scirp.81876-ref40">40</xref>] . Our finding that the inhibition of both thrombotic tendency and atherogenesis by myricetin and G-hesperidin, were in keeping with their strong antioxidant potential, although other factors also might be involved. In this context, Sun et al, recently suggested that hesperidin moderated atherosclerosis not only by anti-oxidative and anti-inflammatory action but also by other pleiotropic effects, including improvement of insulin resistance, amelioration of lipid profiles and inhibition of macrophage foam cell formation [<xref ref-type="bibr" rid="scirp.81876-ref41">41</xref>] . Our results provide convincing direct evidence that myricetin and G-hesperidin inhibited thrombogenesis and atherogenesis. Precise mechanisms underlying this important inhibitory action remain to be fully characterized.</p></sec></sec><sec id="s4"><title>4. Conclusion</title><p>Myricetin and G-hesperidin demonstrated significant inhibitory effects on the development of atherosclerosis and thrombosis in a sensitive murine model. The findings provided new evidence on the mechanism of action of myricetin and hesperidin those are well known to reduce the incidence of coronary disease in elderly humans. Our findings strongly suggested that the prophylactic, daily intake of flavonoids offers a promising strategy for the prevention of cardiovascular diseases and the maintenance of human health.</p></sec><sec id="s5"><title>Acknowledgements</title><p>We would like to thank Dr. IIda at Toyo Sugar Refining Co. Ltd, Tokyo Japan for kindly providing the G-hesperidin.</p></sec><sec id="s6"><title>Author Disclosure Statement</title><p>The authors declare that there are no conflicts of interest regarding the publication of this article.</p></sec><sec id="s7"><title>Cite this paper</title><p>Sasaki, Y., Hyodo, K., Hoshino, A., Kisa, E. Matsuda, K., Horikawa, Y. and Giddings, J.C. (2018) Myricetin and Hesperidin Inhibit Cerebral Thrombogenesis and Atherogenesis in Apoe<sup>−/−</sup> and Ldlr<sup>−/−</sup> Mice. Food and Nutrition Sciences, 9, 20-31. https://doi.org/10.4236/fns.2018.91002</p></sec></body><back><ref-list><title>References</title><ref id="scirp.81876-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Aherne, S.A. and O’Brien, N.M. (1999) Protection by the Flavonoids Myricetin, Quercetin, and Rutin against Hydrogen Peroxide-Induced DNA Damage in Caco-2 and Hep G2 Cells. Nutrition and Cancer, 34, 160-166.  
https://doi.org/10.1207/S15327914NC3402_6</mixed-citation></ref><ref id="scirp.81876-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Griffiths, K., Aggarwal, B.B., Singh, R.B., Buttar, H.S., Wilson, D. and De Meester, F. (2016) Food Antioxidants and Their Anti-Inflammatory Properties: A Potential Role in Cardiovascular Diseases and Cancer Prevention. Diseases, 4, 28.  
https://doi.org/10.3390/diseases4030028</mixed-citation></ref><ref id="scirp.81876-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">González, R., Ballester, I., López-Posadas, R., Suárez, M.D., Zarzuelo, A., Martínez-Augustin, O. and Sánchez de Medina, F. (2011) Effects of Flavonoids and Other Polyphenols on Inflammation. Critical Reviews in Food Science and Nutrition, 51, 331-362. https://doi.org/10.1080/10408390903584094</mixed-citation></ref><ref id="scirp.81876-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Calabriso, N., Scoditti, E., Massaro, M., Pellegrino, M., Storelli, C., Ingrosso, I., Giovinazzo, G. and Carluccio, M.A. (2016) Multiple Anti-Inflammatory and Anti-Atherosclerotic Properties of Red Wine Polyphenolic Extracts: Differential Role of Hydroxycinnamic Acids, Flavonols and Stilbenes on Endothelial Inflammatory Gene Expression. European Journal of Nutrition, 55, 477-489.  
https://doi.org/10.1007/s00394-015-0865-6</mixed-citation></ref><ref id="scirp.81876-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Baby, B., Antony, P. and Vijayan, R. (2017) Antioxidant and Anticancer Properties of Berries. Critical Reviews in Food Science and Nutrition, 1-17.  
https://doi.org/10.1080/10408398.2017.1329198</mixed-citation></ref><ref id="scirp.81876-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Semwal, D.K., Semwal, R.B., Combrinck, S. and Viljoen, A. (2016) Myricetin: A Dietary Molecule with Diverse Biological Activities. Nutrients, 8, 90.  
https://doi.org/10.3390/nu8020090</mixed-citation></ref><ref id="scirp.81876-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Spagnuolo, C., Moccia, S. and Russo, G.L. (2017) Anti-Inflammatory Effects of Flavonoids in Neurodegenerative Disorders. European Journal of Medicinal Chemistry. https://doi.org/10.1016/j.ejmech.2017.09.001</mixed-citation></ref><ref id="scirp.81876-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Niki, E. and Noguchi, N. (2000) Evaluation of Antioxidant Capacity. What Capacity is Being Measured by Which Method. IUBMB Life, 50, 323-329.  
https://doi.org/10.1080/15216540051081119</mixed-citation></ref><ref id="scirp.81876-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Nambiar, S.S., Shetty, N.P., Bhatt, P. and Neelwarne, B. (2014) Inhibition of LDL Oxidation and Oxidized LDL-Induced Foam Cell Formation in RAW 264.7 Cells Show Anti-Atherogenic Properties of a Foliar Methanol Extract of Scoparia dulcis. Pharmacognosy Magazine, 10, 240-248. https://doi.org/10.4103/0973-1296.133241</mixed-citation></ref><ref id="scirp.81876-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Salvamani, S., Gunasekaran, B., Shaharuddin, N.A., Ahmad, S.A. and Shukor, M.Y. (2014) Antiartherosclerotic Effects of Plant Flavonoids. BioMed Research International, 2014, Article ID: 480258.</mixed-citation></ref><ref id="scirp.81876-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Hertog, M.G., Feskens, E.J., Hollman, P.C., Katan, M.B. and Kromhout, D. (1993) Dietary Antioxidant Flavonoids and Risk of Coronary Heart Disease: The Zutphen Elderly Study. Lancet, 342, 1007-1011.  
https://doi.org/10.1016/0140-6736(93)92876-U</mixed-citation></ref><ref id="scirp.81876-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Li, Y., Zheng, X., Yi, X., Liu, C., Kong, D., Zhang, J. and Gong, M. (2017) Myricetin: A Potent Approach for the Treatment of Type 2 Diabetes as a Natural Class B GPCR Agonist. Federation of American Societies for Experimental Biology, 31, 2603-2611.  
https://doi.org/10.1096/fj.201601339R</mixed-citation></ref><ref id="scirp.81876-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, C., Zhang, G., Liao, Y. and Gong, D. (2017) Myricetin Inhibits the Generation of Superoxide Anion by Reduced Form of Xanthine oxidase. Food Chemistry, 221, 1569-1577. https://doi.org/10.1016/j.foodchem.2016.10.136</mixed-citation></ref><ref id="scirp.81876-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Robak, J. and Gryglewski, R.J. (1988) Flavonoids Are Scavengers of Superoxide Anions. Biochemical Pharmacology, 37, 837-841.  
https://doi.org/10.1016/0006-2952(88)90169-4</mixed-citation></ref><ref id="scirp.81876-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Meng, C., Guo, Z., Li, D., Li, H., He, J., Wen, D. and Luo, B. (2017) Preventive Effect of Hesperidin Modulates Inflammatory Responses and Antioxidant Status Following Acute Myocardial Infarction through the Expression of PPAR-γ and Bcl-2 in Model Mice. Molecular Medicine Reports, 1261-1268. 
https://doi.org/10.3892/mmr.2017.7981</mixed-citation></ref><ref id="scirp.81876-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ikemura, M., Sasaki, Y., Giddings, J.C. and Yamamoto, J. (2012) Preventive Effects of Hesperidin, Glucosyl Hesperidin and Naringin on Hypertension and Cerebral Thrombosis in Stroke-Prone Spontaneously Hypertensive Rats. Phytotherapy Research, 26, 1272-1277. https://doi.org/10.1002/ptr.3724</mixed-citation></ref><ref id="scirp.81876-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Ikemura, M., Sasaki, Y., Giddings, J.C. and Yamamoto, J. (2012) Protective Effects of Nobiletin on Hypertension and Cerebral Thrombosis in Stroke-Prone Spontaneously Hypertensive Rats (SHRSP). Food and Nutrition Sciences, 3, 1539-1546.  
https://doi.org/10.4236/fns.2012.311201</mixed-citation></ref><ref id="scirp.81876-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Demonty, I., Lin, Y., Zebregs, Y.E., Vermeer, M.A., van der Knaap, H.C., J&amp;auml;kel, M. and Trautwein, E.A. (2010) The Citrus Flavonoids Hesperidin and Naringin Do Not Affect Serum Cholesterol in Moderately Hypercholesterolemic Men and Women. Journal of Nutrition, 140, 1615-1620. https://doi.org/10.3945/jn.110.124735</mixed-citation></ref><ref id="scirp.81876-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Zmyslowski, A. and Szterk, A. (2017) Current Knowledge on the Mechanism of Atherosclerosis and Pro-Atherosclerotic Properties of Oxysterols. Lipids in Health and Disease, 16, 188. https://doi.org/10.1186/s12944-017-0579-2</mixed-citation></ref><ref id="scirp.81876-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Kattoor, A.J., Pothineni, N.V.K., Palagiri, D. and Mehta, J.L. (2017) Oxidative Stress in Atherosclerosis. Current Atherosclerosis Reports, 19, 42.  
https://doi.org/10.1007/s11883-017-0678-6</mixed-citation></ref><ref id="scirp.81876-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Langheinrich, A.C., Michniewicz, A., Bohle, R.M. and Ritman, E.L. (2007) Vasa Vasorum Neovascularization and Lesion Distribution among Different Vascular Beds in ApoE-/-/LDL-/- Double Knockout Mice. Atherosclerosis, 191, 73-81.  
https://doi.org/10.1016/j.atherosclerosis.2006.05.021</mixed-citation></ref><ref id="scirp.81876-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Kampschulte, M., St&amp;ouml;ckl, C., Langheinrich, A.C., Alth&amp;ouml;hn, U., Bohle, R.M., Krombach, G.A., Stieger, P., Churin, Y., Kremer, S., Dierkes, C., Rath, T., Roeb, E. and Roderfeld, M. (2014) Western Diet in ApoE-LDLR Double-Deficient Mouse Model of Atherosclerosis Leads to Hepatic Steatosis, Fibrosis, and Tumorigenesis. Laboratory Investigation, 94, 1273-1282. https://doi.org/10.1038/labinvest.2014.112</mixed-citation></ref><ref id="scirp.81876-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Yeadon, J. (2015) Which Jax Mouse Model Is Best for Atherosclerosis Studies: Apoe or LDLR Knockout Mice? Jackson Laboratory.  
https://www.jax.org/news-and-insights/jax-blog/2013/november/which-jax-mouse-model-is-best-for-atherosclerosis-studies-apoe-or-ldlr-knoc</mixed-citation></ref><ref id="scirp.81876-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">The Physiological Society of Japan (P.S.J.) Guiding Principles for the Care and Use of Animals in the Field of Physiological Sciences. Sciences. (In Japanese)  
http://physiology.jp/guidance/4802/</mixed-citation></ref><ref id="scirp.81876-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Geng, Y., Sun, Q., Li, W., Lu, Z.M., Xu, H.Y., Shi, J.S. and Xu, Z.H. (2017) The Common Dietary Flavonoid Myricetin Attenuates Liver Fibrosis in Carbon Tetrachloride Treated Mice. Molecular Nutrition &amp; Food Research, 61.</mixed-citation></ref><ref id="scirp.81876-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, N., Feng, H., Liao, H.H., Chen, S., Yang, Z., Deng, W. and Tang, Q.Z. (2017) Myricetin Attenuated LPS Induced Cardiac Injury in Vivo and in Vitro. Phytotherapy Research. https://doi.org/10.1002/ptr.5989</mixed-citation></ref><ref id="scirp.81876-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Morii, S., Ngai, A.C. and Winn, H.R. (1986) Reactivity of Rat Pial Arterioles and Venules to Adenosine and Carbon Dioxide: With Detailed Description of the Closed Cranial Window Technique in Rats. Journal of Cerebral Blood Flow &amp; Metabolism, 6, 34-41. https://doi.org/10.1038/jcbfm.1986.5</mixed-citation></ref><ref id="scirp.81876-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Sasaki, Y., Noguchi, T., Yamamoto, E., Giddings, J.C., Ikeda, K., Yamori, Y. and Yamamoto, J. (2002) Effects of Ginkgo biloba Extract (EGB 761) on Cerebral Thrombosis and Blood Pressure in Stroke-Prone Spontaneously Hypertensive Rats. Clinical and Experimental Pharmacology and Physiology, 29, 963-967.  
https://doi.org/10.1046/j.1440-1681.2002.03761.x</mixed-citation></ref><ref id="scirp.81876-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Paigen, B., Morrow, A., Holmes, P.A., Mitchell, D. and Williams, R.A. (1987) Quantitative Assessment of Atherosclerotic Lesions in Mice. Atherosclerosis, 68, 231-240.  
https://doi.org/10.1016/0021-9150(87)90202-4</mixed-citation></ref><ref id="scirp.81876-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Tangirala, R.K., Rubin, E.M. and Palinski, W. (1995) Quantitation of Atherosclerosis in Murine Models: Correlation between Lesions in the Aortic Origin and in the Entire Aorta, and Differences in the Extent of Lesions between Sexes in LDL Receptor-Deficient and Apolipoprotein E-Deficient Mice. The Journal of Lipid Research, 36, 2320-2328.</mixed-citation></ref><ref id="scirp.81876-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Kashima-Tanaka, M., Tsujimoto, Y., Kawamoto, K., Senda, N., Ito, K. and Yamazaki, M. (2003) Generation of Free Radicals and/or Active Oxygen by Light or Laser Irradiation of Hydrogen Peroxide or Sodium Hypochlorite. Journal of Endodontics, 29, 141-143. https://doi.org/10.1097/00004770-200302000-00013</mixed-citation></ref><ref id="scirp.81876-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Touyz, R.M. and Briones, A.M. (2011) Reactive Oxygen Species and Vascular Biology: Implications in Human Hypertension. Hypertension Research, 34, 5-14.  
https://doi.org/10.1038/hr.2010.201</mixed-citation></ref><ref id="scirp.81876-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Rodrigo, R., González, J. and Paoletto, F. (2011) The Role of Oxidative Stress in the Pathophysiology of Hypertension. Hypertension Research, 34, 431-440.  
https://doi.org/10.1038/hr.2010.264</mixed-citation></ref><ref id="scirp.81876-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Povlishock, J.T. and Rosenblum, W.I. (1987) Injury of Brain Microvessels with a Helium-Neon Laser and Evans Blue Can Elicit Local Platelet Aggregation without Endothelial Denudation. Archives of Pathology &amp; Laboratory Medicine, 111, 415- 421.</mixed-citation></ref><ref id="scirp.81876-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Wachowicz, B., Olas, B., Zbikowska, H.M. and Buczyński, A. (2002) Generation of Reactive Oxygen Species in Blood Platelets. Platelets, 13, 175-182.  
https://doi.org/10.1080/09533710022149395</mixed-citation></ref><ref id="scirp.81876-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Tzeng, S.H., Ko, W.C., Ko, F.N. and Teng, C.M. (1991) Inhibition of Platelet Aggregation by Some Flavonoids. Thrombosis Research, 64, 91-100.  
https://doi.org/10.1016/0049-3848(91)90208-E</mixed-citation></ref><ref id="scirp.81876-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Guerrero, J.A., Navarro-Nu&amp;ntilde;ez, L., Lozano, M.L., Martínez, C., Vicente, V., Gibbins, J.M. and Rivera, J. (2007) Flavonoids Inhibit the Platelet TxA2 Signalling Pathway and Antagonize TxA2 Receptors (TP) in Platelets and Smooth Muscle Cells. British Journal of Clinical Pharmacology, 64, 133-144.  
https://doi.org/10.1111/j.1365-2125.2007.02881.x</mixed-citation></ref><ref id="scirp.81876-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Rong, Z., Pan, R., Xu, Y., Zhang, C., Cao, Y. and Liu, D. (2013) Hesperidin Pretreatment Protects Hypoxia-Ischemic Brain Injury in Neonatal Rat. Neuroscience, 255, 292-299. https://doi.org/10.1016/j.neuroscience.2013.09.030</mixed-citation></ref><ref id="scirp.81876-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Mastantuono, T., Battiloro, L., Sabatino, L., Chiurazzi, M., Di Maro, M., Muscariello, E., Colantuoni, A. and Lapi, D. (2015) Effects of Citrus Flavonoids against Microvascular Damage Induced by Hypoperfusion and Reperfusion in Rat Pial Circulation. Microcirculation, 22, 378-390. https://doi.org/10.1111/micc.12207</mixed-citation></ref><ref id="scirp.81876-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Bertin, R., Chen, Z., Marin, R., Donati, M., Feltrinelli, A., Montopoli, M., Zambon, S., Manzato, E. and Froldi, G. (2016) Activity of Myricetin and Other Plant-Derived Polyhydroxyl Compounds in Human LDL and Human Vascular Endothelial Cells against Oxidative Stress. Biomedicine &amp; Pharmacotherapy, 82, 472-478.  
https://doi.org/10.1016/j.biopha.2016.05.019</mixed-citation></ref><ref id="scirp.81876-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Sun, Y.Z., Chen, J.F., Shen, L.M., Zhou, J. and Wang, C.F. (2017) Anti-Atherosclerotic Effect of Hesperidin in LDLR-/- Mice and Its Possible Mechanism. European Journal of Pharmacology, 815, 109-117.  
https://doi.org/10.1016/j.ejphar.2017.09.010</mixed-citation></ref></ref-list></back></article>